Canada markets closed

Terns Pharmaceuticals, Inc. (TERN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.81+0.35 (+4.69%)
At close: 04:00PM EDT
7.99 +0.18 (+2.30%)
After hours: 07:56PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-95,895
-90,210
-60,345
-50,158
-40,053
Depreciation & amortization
918
881
1,032
512
394
Deferred income taxes
145
141
392
219
693
Stock based compensation
25,813
25,536
10,768
8,146
1,691
Change in working capital
-5,800
1,291
-1,037
-1,425
5,060
Accounts Payable
-3,664
1,149
-722
1,727
-1,146
Other working capital
-79,086
-67,442
-49,384
-42,167
-30,393
Other non-cash items
-
-
-
-
2,887
Net cash provided by operating activites
-78,992
-67,390
-49,109
-41,827
-29,809
Cash flows from investing activities
Investments in property, plant and equipment
-
-52
-275
-340
-584
Purchases of investments
-119,682
-275,781
-139,731
-166,297
-715
Sales/Maturities of investments
194,883
237,846
117,734
46,941
7,992
Net cash used for investing activites
75,107
-37,987
-22,272
-119,696
6,693
Cash flows from financing activities
Debt repayment
-
-
0
-12,880
0
Common stock issued
13,687
41,611
167,253
136,362
0
Other financing activites
-
-344
-401
9,997
-858
Net cash used privided by (used for) financing activities
14,281
41,951
167,095
134,393
85,515
Net change in cash
10,577
-63,309
95,536
-27,155
62,479
Cash at beginning of period
80,919
143,235
47,699
74,854
12,375
Cash at end of period
91,315
79,926
143,235
47,699
74,854
Free Cash Flow
Operating Cash Flow
-78,992
-67,390
-49,109
-41,827
-29,809
Capital Expenditure
-
-52
-275
-340
-584
Free Cash Flow
-79,086
-67,442
-49,384
-42,167
-30,393